- Home
- BMR vs YI Comparison
BMR vs YI Comparison
Compare BMR & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- YI
- Stock Information
- Founded
- BMR 2009
- YI 2010
- Country
- BMR Israel
- YI China
- Employees
- BMR N/A
- YI N/A
- Industry
- BMR Computer Software: Prepackaged Software
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- BMR Technology
- YI Consumer Staples
- Exchange
- BMR Nasdaq
- YI Nasdaq
- Market Cap
- BMR 59.3M
- YI 71.1M
- IPO Year
- BMR 2023
- YI N/A
- Fundamental
- Price
- BMR $3.87
- YI $0.43
- Analyst Decision
- BMR
- YI
- Analyst Count
- BMR 0
- YI 0
- Target Price
- BMR N/A
- YI N/A
- AVG Volume (30 Days)
- BMR 716.0K
- YI 392.6K
- Earning Date
- BMR 08-06-2024
- YI 11-27-2024
- Dividend Yield
- BMR N/A
- YI N/A
- EPS Growth
- BMR N/A
- YI N/A
- EPS
- BMR N/A
- YI N/A
- Revenue
- BMR $2,955,000.00
- YI $2,090,255,896.00
- Revenue This Year
- BMR $21.52
- YI $61.85
- Revenue Next Year
- BMR N/A
- YI N/A
- P/E Ratio
- BMR N/A
- YI N/A
- Revenue Growth
- BMR 2.25
- YI N/A
- 52 Week Low
- BMR $1.41
- YI $0.41
- 52 Week High
- BMR $34.94
- YI $1.60
- Technical
- Relative Strength Index (RSI)
- BMR 48.56
- YI 30.18
- Support Level
- BMR $4.25
- YI $0.41
- Resistance Level
- BMR $4.23
- YI $0.54
- Average True Range (ATR)
- BMR 0.75
- YI 0.07
- MACD
- BMR -0.11
- YI -0.02
- Stochastic Oscillator
- BMR 11.69
- YI 4.31
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.